Company: INMB
Filing Date: 2025-12-08
Form Type: 8-A12B/A
Source: 0001213900-25-119251
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-12-08
Form: 8-A12B/A
Chunk 1
---
2, December 18, 2023 and December 9, 2024, respectively.

<div align='center'>1</div>

Item 1. Description of Registrant’s Securities to be Registered.

On December 5, 2025, INmune Bio Inc. (the “Company”) entered
into Amendment No. 5 (the “Amendment”) to the Rights Agreement, dated as of December 30, 2020, between the Company and VStock
Transfer, LLC, as Rights Agent, as amended (the “Rights Agreement”). Capitalized terms used but not otherwise defined herein
shall have the meanings ascribed to such terms in the Rights Agreement.

The Amendment extended the expiration of the Rights
Agreement to December 31, 2026 and provides that such expiration date will automatically extend for successive one-year terms unless the
Company’s Board of Directors determines not to extend the Rights Agreement.

The foregoing description of the Amendment is qualified in its entirety
by reference to the full text of the Rights Agreement and the Amendment, each of which is attached hereto as an exhibit and is incorporated
herein by reference.

Item 2. Exhibits.

See the Exhibit Index below, which is incorporated
by reference herein.

EXHIBIT INDEX

| Exhibit Number 
 4.1            
 4.2            |     | Description                                                                                                                                                                                                                                
 Rights Agreement, dated as of December 30, 2020 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 30, 2020).                                                            
 Amendment No. 1 to Rights Agreement, dated as of December 20, 2021, between INmune Bio Inc. and Vstock Transfer LLC (incorporated by reference to the Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 21, 2021). |
|:---------------|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3            |     | Amendment No. 2 to Rights Agreement, dated as of December 9, 2022, between INmune Bio Inc. and Vstock Transfer LLC (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 12, 2022)       |
| 4.4            |     | Amendment No. 3 to Rights Agreement, dated as of December